- 米国企業
- Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc.MRSN
時価総額
$3.3億
PER
2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | |
Collaboration revenue | 18 | 11 | 42 | 1 | 0 | 27 | 37 |
Research and development | 47 | 60 | 55 | 67 | 132 | 173 | 148 |
General and administrative | 10 | 16 | 17 | 22 | 37 | 57 | 60 |
Total operating expenses | 57 | 76 | 72 | 89 | 169 | 230 | 217 |
Restructuring Charges | - | - | - | - | - | - | 9 |
Total operating expenses | 57 | 76 | 72 | 89 | 169 | 230 | 217 |
Interest income | - | - | 2 | 0 | 0 | 3 | 12 |
Interest expense | - | - | 0 | 0 | 1 | 3 | 4 |
Total other income (expense), net | 1 | 1 | 2 | 0 | -1 | -0 | 8 |
Net loss | -39 | -64 | -28 | -88 | -170 | -204 | -172 |
Unrealized gain (loss) on marketable securities | -0 | 0 | 0 | -0 | - | -0 | 0 |
Comprehensive loss | -39 | -64 | -28 | -88 | -170 | -204 | -172 |
Net loss attributable to common stockholders - basic | -39 | -64 | -28 | -88 | -170 | -204 | -172 |
Net loss attributable to common stockholders - diluted | -39 | - | -28 | -88 | -170 | -204 | -172 |
Earnings Per Share, Basic | - | - | - | - | -2.41 | -2.18 | -1.48 |
Earnings Per Share, Diluted | - | - | - | - | -2.41 | -2.18 | -1.48 |